A forward chemical screen in zebrafish identifies a retinoic acid derivative with receptor specificity

Autor: Randall T. Peterson, Ting-Chun Liu, Kellie McCartin, Todd Evans, Bhaskar C. Das
Jazyk: angličtina
Rok vydání: 2010
Předmět:
Embryo
Nonmammalian

Receptors
Retinoic Acid

medicine.drug_class
Drug Evaluation
Preclinical

Retinoic acid
lcsh:Medicine
Antineoplastic Agents
Tretinoin
Biology
Pharmacology
Retinoid X receptor
01 natural sciences
Small Molecule Libraries
Retinoids
Developmental Biology/Molecular Development
03 medical and health sciences
chemistry.chemical_compound
Chemical Biology
medicine
Animals
Retinoid
lcsh:Science
Zebrafish
Developmental Biology/Embryology
030304 developmental biology
0303 health sciences
Multidisciplinary
Retinoid X receptor alpha
Developmental Biology/Morphogenesis and Cell Biology
010405 organic chemistry
lcsh:R
biology.organism_classification
Retinoid X receptor gamma
0104 chemical sciences
Cell biology
chemistry
Chemical Biology/Biomimetic Chemistry
lcsh:Q
Retinoid X receptor beta
Protein Binding
Research Article
Developmental Biology
medicine.drug
Zdroj: PLoS ONE, Vol 5, Iss 4, p e10004 (2010)
PLoS ONE
ISSN: 1932-6203
Popis: Background Retinoids regulate key developmental pathways throughout life, and have potential uses for differentiation therapy. It should be possible to identify novel retinoids by coupling new chemical reactions with screens using the zebrafish embryonic model. Principal Findings We synthesized novel retinoid analogues and derivatives by amide coupling, obtaining 80–92% yields. A small library of these compounds was screened for bioactivity in living zebrafish embryos. We found that several structurally related compounds significantly affect development. Distinct phenotypes are generated depending on time of exposure, and we characterize one compound (BT10) that produces specific cardiovascular defects when added 1 day post fertilization. When compared to retinoic acid (ATRA), BT10 shows similar but not identical changes in the expression pattern of embryonic genes that are known targets of the retinoid pathway. Reporter assays determined that BT10 interacts with all three RAR receptor sub-types, but has no activity for RXR receptors, at all concentrations tested. Conclusions Our screen has identified a novel retinoid with specificity for retinoid receptors. This lead compound may be useful for manipulating components of retinoid signaling networks, and may be further derivatized for enhanced activity.
Databáze: OpenAIRE